Literature DB >> 10936859

Pneumococcal vaccine administration associated with splenectomy: the need for improved education, documentation, and the use of a practical checklist.

M L Brigden1, A Pattullo, G Brown.   

Abstract

An audit was performed of the documentation of pneumococcal vaccination in splenectomy patients in three major hospitals involving a geographical population base of 350,000 patients in British Columbia, Canada. Overall, 111 of the 164 hospitalized splenectomy patients (68%) had received pneumococcal vaccination. Of elective splenectomy cases, only 11 of 55 (20%) had been vaccinated prior to surgery, as is currently recommended. One hundred fifty-five patients (95%) had splenectomy status mentioned in the discharge summary. However, only 35 (21%) had mention of vaccination status, 10 (6%) mention of the need for future revaccination, and only 8 (5%) notation of the possibility of future infectious risks. The rate of pneumococcal vaccination was as satisfactory as any reported in the literature to date. However, there is need for improved education in relation to the timing of vaccination and discharge summary documentation. A checklist for potential splenectomy patients may aid in improving this situation as may geographically based splenectomy registries. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936859     DOI: 10.1002/1096-8652(200009)65:1<25::aid-ajh4>3.0.co;2-8

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies.

Authors:  L Bruni; J M Bayas; A Vilella; A Conesa
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

2.  Survey of vaccine administration to splenectomized patients: Are guidelines being followed?

Authors:  Andrea K Kew; Darrell White; Kathryn Slayter
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

3.  Management of post-splenectomy patients in the Netherlands.

Authors:  A J J Lammers; D Veninga; M J M H Lombarts; J B L Hoekstra; P Speelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-22       Impact factor: 3.267

4.  Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study.

Authors:  Antonio Di Sabatino; Marco Vincenzo Lenti; Francesco Paolo Tinozzi; Marina Lanave; Ivana Aquino; Catherine Klersy; Piero Marone; Carlo Marena; Andrea Pietrabissa; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2017-08-10       Impact factor: 3.397

5.  Management of patients undergoing splenectomy in an Irish teaching hospital: impact of guidelines.

Authors:  J O'Donnell; G McGreal; P Daly; R Crowley; M C Barry; P Broe; D J Bouchier-Hayes
Journal:  Ir J Med Sci       Date:  2004 Jul-Sep       Impact factor: 1.568

Review 6.  Is it worth investigating splenic function in patients with celiac disease?

Authors:  Antonio Di Sabatino; Laura Brunetti; Gabriella Carnevale Maffè; Paolo Giuffrida; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

7.  Antibody response to influenza vaccination in splenectomized patients in Poland.

Authors:  Lidia B Brydak; Magdalena Machała; Paweł Łaguna; Roma Rokicka-Milewska
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

8.  An audit of splenectomies in a teaching hospital in North India. Are postsplenectomy guidelines being complied with?

Authors:  M Deodhar; N Kakkar
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

9.  Splenectomy for hematological disorders in Iranian pediatric patients: a single center study.

Authors:  Bibi Shahin Shamsian; Mohammad Thaghi Arzanian; Raheleh Kaviani; Samin Alavi; Mona Hedayat; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

Review 10.  Assessment of splenic function.

Authors:  A P N A de Porto; A J J Lammers; R J Bennink; I J M ten Berge; P Speelman; J B L Hoekstra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-19       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.